Skip to content

Effect of two pancreatic jejunostomy methods on the prognosis of patients: a case records based retrospective study

Effect of two pancreatic jejunostomy methods on the prognosis of patients: a case records based retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020991
Enrollment
Unknown
Registered
2019-01-24
Start date
2012-01-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer,cholangiocarcinoma

Interventions

Sponsors

Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) patients aged 18 to 80 years old; 2) preoperative imaging and laboratory examination diagnosed hilar cholangiocarcinoma and pancreatic cancer, intraoperative frozen and postoperative pathology confirmed malignant tumor of the bile duct; Preoperative imaging evaluation was resectable; 3) child-turcotte-pugh liver function score a-b; 4) the patient has the ability to understand and voluntarily sign the written informed consent, and can complete the follow-up plan.

Exclusion criteria

Exclusion criteria: 1) the patient has obvious cardiac, pulmonary, brain and renal insufficiency that affects the surgical treatment; 2) the patient has a history of other malignant tumors; 3) child-turcotte-pugh score of liver function grade C; 4) pregnant or lactating female patients; 5) uncomplete clinical data. The investigator determines that he/she is not suitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Amylase ascites;body mass index;survival;age;sex;The pancreas texture;The pancreatic duct diameter;The operation time;Intraoperative blood loss;Pancreatic fistula level;

Countries

China

Contacts

Public ContactLei Zhang

Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University

Doctorzhanglei@gmail.com+86 13936179062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026